By Editor , 8 September 2026
Helfie AI Names John Rego CFO After $10B in Capital Raises

Melbourne, Australia – September 07, 2026 -- Helfie AI has appointed John Rego as Chief Financial Officer, bringing a track record of raising more than $10 billion in capital and closing over two dozen M&A transactions across six public and private companies.

By Editor , 4 September 2026
SIBIONICS Unveils AI-Powered GS3 Glucose Sensor at Melbourne Congress

Melbourne – September 04, 2026 -- SIBIONICS showcased its GS3 continuous glucose monitoring (CGM) sensor, integrating artificial intelligence for meal logging, food analysis and glucose trend insights, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21.

By Editor , 4 September 2026
Kazia Therapeutics Closes Oversubscribed Offering, Up to $120M Raised

Sydney – September 04, 2026 -- Kazia Therapeutics Limited (NASDAQ: KZIA) has closed an oversubscribed, tranched public offering that generated approximately $40 million in upfront gross proceeds, with total potential proceeds reaching approximately $120 million if milestone-linked warrants are fully exercised.

By Editor , 3 September 2026
SIBIONICS Unveils AI-Powered GS3 Glucose Sensor at Melbourne Congress

Melbourne – September 03, 2026 -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne, held August 18-21 and featuring a company booth, a scientific symposium and on-site interviews with certified diabetes educators (CDEs).

By Editor , 3 September 2026
SIBIONICS Unveils AI-Powered GS3 Glucose Sensor at Melbourne Congress

Melbourne – September 03, 2026 -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21, using a dedicated booth, a scientific symposium and on-site interviews with credentialed diabetes educators (CDEs).

By Editor , 2 September 2026

MELBOURNE, Australia -- Aug. 31, 2026 -- Copenhagen Infrastructure Partners has acquired the Gawara Baya hybrid wind and battery project in North Queensland on behalf of its fifth flagship fund, Copenhagen Infrastructure V. CIP reached financial close on a AUD 1.7 billion facility backed by 10 banks after securing all major approvals and taking a final investment decision. The project was bought from Australian developer Windlab. Construction has now started, with commercial operation targeted for 2030.

By Editor , 2 September 2026

MELBOURNE, Australia -- September 01, 2026 -- Copenhagen Infrastructure Partners (CIP) has reached financial close on Gawara Baya, a hybrid onshore wind and battery storage project in North Queensland, securing a AUD 1.7 billion facility from 10 banks. The acquisition, made on behalf of CIP's fifth flagship fund, Copenhagen Infrastructure V, follows receipt of all major approvals and a final investment decision. CIP bought the project from Australian developer Windlab. Construction has now started, with the project expected to be fully operational in 2030.

By Editor , 2 September 2026
SIBIONICS Presents AI-Linked GS3 Glucose Sensor at Melbourne Diabetes Congress

Melbourne, Australia -- September 01, 2026 -- SIBIONICS presented its GS3 continuous glucose monitor at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from August 18 to 21, 2026. The company used Booth #1, a scientific symposium and on-site interviews with credentialled diabetes educators to demonstrate the sensor's AI-linked meal-logging and glucose-trend features. GS3 is a factory-calibrated, 14-day continuous glucose monitor with a 2.9 mm on-body profile.